|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#pathogenesis
|
http://purl.obolibrary.org/obo/GO_0009405
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#Valproic_acid
|
http://www.drugbank.ca/drugs/DB00313
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#heparin
|
http://www.drugbank.ca/drugs/DB01109
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#death
|
http://purl.obolibrary.org/obo/GO_0016265
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#ruxolitinib
|
http://www.drugbank.ca/drugs/DB08877
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#Tamoxifen
|
http://www.drugbank.ca/drugs/DB00675
|
LOOM
|
|
http://www.semanticweb.org/cjf/ontologies/2022/8/NeuralReprogrammingOntology(NRO)#tranylcypromine
|
http://www.drugbank.ca/drugs/DB00752
|
LOOM
|